Aromatic pyrrolidine amide prolyl endopeptidase inhibitors
US5847155A · kind A · utility
1Cited by
5References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 26, 1996 |
| Grant date | Dec 8, 1998 |
| Priority date | — |
| Expiry date | Jan 26, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D493/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A series of aromatic pyrrolidine derivatives and suitable pharmaceutically acceptable salts thereof are disclosed. These compounds are useful as PEP inhibitors in the treatment of Alzheimer's disease, amnesia, dementia, anxiety ischemia, or stroke.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.